Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Sep 27;288(39):27881-7.
doi: 10.1074/jbc.M113.491134. Epub 2013 Aug 19.

Unique substrate recognition mechanism of the botulinum neurotoxin D light chain

Affiliations

Unique substrate recognition mechanism of the botulinum neurotoxin D light chain

Jiubiao Guo et al. J Biol Chem. .

Abstract

Botulinum neurotoxins are the most potent protein toxins in nature. Despite the potential to block neurotransmitter release at the neuromuscular junction and cause human botulism, they are widely used in protein therapies. Among the seven botulinum neurotoxin serotypes, mechanisms of substrate recognition and specificity are known to a certain extent in the A, B, E, and F light chains, but not in the D light chain (LC/D). In this study, we addressed the unique substrate recognition mechanism of LC/D and showed that this serotype underwent hydrophobic interactions with VAMP-2 at its V1 motif. The LC/D B3, B4, and B5 binding sites specifically recognize the hydrophobic residues in the V1 motif of VAMP-2. Interestingly, we identified a novel dual recognition mechanism employed by LC/D in recognition of VAMP-2 sites at both the active site and distal binding sites, in which one site of VAMP-2 was recognized by two independent, but functionally similar LC/D sites that were complementary to each other. The dual recognition strategy increases the tolerance of LC/D to mutations and renders it a good candidate for engineering to improve its therapeutic properties. In conclusion, in this study, we identified a unique multistep substrate recognition mechanism by LC/D and provide insights for LC/D engineering and antitoxin development.

Keywords: Bacterial Toxins; Enzyme Catalysis; Enzyme Kinetics; Metalloprotease; Neurotoxin.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Overall view of the modeled LC/D·VAMP-2 complex structure. Left panel, view of the active site side; right panel, view after a 90° clockwise turn. LC/D is shown as a surface structure, and VAMP-2 is shown as a ribbon structure. The active site recognition and binding site interactions are highlighted. Negatively charged residues are shown in red, positively charged residues are shown in blue, hydrophobic residues are shown in gray, and polar residues are shown in green.
FIGURE 2.
FIGURE 2.
CD spectroscopy analysis of LC/D and its derivatives. Far-UV CD (200–250 nm) data were obtained for LC/D and its derivatives with a JASCO J-810 spectropolarimeter at room temperature. The data for the most representative LC/D derivatives are shown in different colors.
FIGURE 3.
FIGURE 3.
Specific recognition of VAMP-2 by LC/D pockets. Shown are surface representations of the recognition of different P sites of VAMP-2 by the S pockets and recognition of VAMP-2-binding sites by the B1–B5 binding sites of LC/D. Negatively charged residues are shown in red, positively charged residues are shown in blue, hydrophobic residues are shown in gray, and polar residues are shown in green. a, recognition of the P sites of VAMP-2 by the active site pockets of LC/D. The P2′ site (Ser61) of VAMP-2 is recognized by the S2′ pocket (Arg372). The P1′ site (Leu60) of VAMP-2 is recognized by the S1′ pocket (Tyr168 and Leu200) of LC/D. The P1 site (Lys59) of VAMP-2 interacts with the oxygen atom of Pro64 of LC/D. The P3 site (Asp57) of VAMP-2 is recognized by the S3 pocket (Arg63) of LC/D. b, recognition of Val53 by the B1 binding site (Phe50 and Ile191) of LC/D. c, recognition of Asn49 of VAMP-2 by the B2 binding site (Arg23 and His132) of LC/D and recognition of Met46 of VAMP-2 by the B3 binding site (Val148 and Ile151) of LC/D. d, recognition of Val42 by the B4 binding site (Trp315) of LC/D and recognition of Val39 by the B5 binding site (Trp44, Ile152, and Pro154) of LC/D.
FIGURE 4.
FIGURE 4.
Mechanism of substrate recognition by LC/D. After internalization to the cytoplasm of neuronal cells, LC/D attacks the free form of VAMP-2 through interaction with and recognition of hydrophobic residues in the V1 motif of VAMP-2, including Val39, Val42, and Met46, by the substrate-binding regions B5, B4, and B3 of LC/D on the substrate-binding cleft, respectively. In particular, binding of Met46 of VAMP-2 to the LC/D B3 binding site was suggested to be very important for LC/D substrate recognition. This binding facilitates further binding of VAMP-2 Asn49 and Val53 to the B2 and B1 binding sites located at the active site surface of LC/D. The recognition of VAMP-2 Val53 by the LC/D Phe50/Ile191 pocket further orientates and stabilizes VAMP-2 for subsequent recognition of different P sites of VAMP-2 by the corresponding S pockets in the active site of LC/D. Active P site recognition includes the formation of a salt bridge between P3 (Asp57) of VAMP-2 and S3 (Arg63) of LC/D, a hydrogen bond interaction between P1 (Lys58) of VAMP-2 and the main chain oxygen atom of Pro64, recognition of P1′ (Leu60) of VAMP-2 by the S1′ pocket (Tyr168 and Leu200) of LC/D, and finally a hydrogen bond interaction between P2′ (Ser61) of VAMP-2 and the S2′ pocket (Arg372) of LC/D. The anchoring of VAMP-2 P sites to different S pockets in the active site of LC/D aligns the VAMP-2 scissile bond close enough to the active site zinc ion to facilitate peptide bond cleavage.

Similar articles

Cited by

References

    1. Montecucco C., Schiavo G. (1993) Tetanus and botulism neurotoxins: a new group of zinc proteases. Trends Biochem. Sci. 18, 324–327 - PubMed
    1. Montecucco C., Schiavo G. (1994) Mechanism of action of tetanus and botulinum neurotoxins. Mol. Microbiol. 13, 1–8 - PubMed
    1. Jankovic J., Brin M. F. (1991) Therapeutic uses of botulinum toxin. N. Engl. J. Med. 324, 1186–1194 - PubMed
    1. Schiavo G., Rossetto O., Benfenati F., Poulain B., Montecucco C. (1994) Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus. Ann. N.Y. Acad. Sci. 710, 65–75 - PubMed
    1. Davletov B., Bajohrs M., Binz T. (2005) Beyond BOTOX: advantages and limitations of individual botulinum neurotoxins. Trends Neurosci. 28, 446–452 - PubMed

Publication types

LinkOut - more resources